Recent studies have shown that autophagy plays a critical role in NAFLD and that ASPP2 inhibits autophagy [22]; therefore, we examined whether the elimination of excessive intracellular lipids was associated with ASPP2-mediated autophagy. This evidence concerns the gene TP53BP2 and metabolic dysfunction-associated steatotic liver disease.